[Federal Register Volume 67, Number 218 (Tuesday, November 12, 2002)]
[Notices]
[Page 68686]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-28657]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated September 25, 2001, and published in the Federal 
Register on October 3, 2001 (66 FR 50453), Cambridge Isotope Lab, 50 
Frontage Road, Andover, Massachusetts 01810, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the basic classes of controlled substances 
listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methaqualone (2565).........................  I
Dimethyltryptamine (7435)...................  I
Amphetamine (1100)..........................  II
Methamphetamine (1105)......................  II
Pentobarbital (2270)........................  II
Secobarbital (2315).........................  II
Phencyclidine (7471)........................  II
Cocaine (9041)..............................  II
Codeine (9050)..............................  II
Oxycodone (9143)............................  II
Hydromorphone (9150)........................  II
Benzoylecgonine (9180)......................  II
Methadone (9250)............................  II
Dextropropoxyphene, bulk (non-dosage forms)   II
 (9273).
Morphine (9300).............................  II
Fentanyl (9801).............................  II
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of the listed 
controlled substances to produce isotope labeled standards for drug 
analysis.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Cambridge Isotope Lab to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Cambridge Isotope 
Lab on a regular basis to ensure that its continued registration is 
consistent with the public interest. These investigations have included 
inspection and testing of the company's physical security systems, 
audits of the company's records, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 
0.100 and 0.104, the Deputy Assistant Administrator, Office of 
Diversion Control, hereby orders that the application submitted by the 
above firm for registration as a bulk manufacturer of the basic classes 
of controlled substances listed above is granted.

    Dated: October 21, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-28657 Filed 11-8-02; 8:45 am]
BILLING CODE 4410-09-M